• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类MutSα DNA损伤识别复合物的结构。

Structure of the human MutSalpha DNA lesion recognition complex.

作者信息

Warren Joshua J, Pohlhaus Timothy J, Changela Anita, Iyer Ravi R, Modrich Paul L, Beese Lorena S

机构信息

Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Mol Cell. 2007 May 25;26(4):579-92. doi: 10.1016/j.molcel.2007.04.018.

DOI:10.1016/j.molcel.2007.04.018
PMID:17531815
Abstract

Mismatch repair (MMR) ensures the fidelity of DNA replication, initiates the cellular response to certain classes of DNA damage, and has been implicated in the generation of immune diversity. Each of these functions depends on MutSalpha (MSH2*MSH6 heterodimer). Inactivation of this protein complex is responsible for tumor development in about half of known hereditary nonpolyposis colorectal cancer kindreds and also occurs in sporadic tumors in a variety of tissues. Here, we describe a series of crystal structures of human MutSalpha bound to different DNA substrates, each known to elicit one of the diverse biological responses of the MMR pathway. All lesions are recognized in a similar manner, indicating that diversity of MutSalpha-dependent responses to DNA lesions is generated in events downstream of this lesion recognition step. This study also allows rigorous mapping of cancer-causing mutations and furthermore suggests structural pathways for allosteric communication between different regions within the heterodimer.

摘要

错配修复(MMR)确保DNA复制的保真度,引发细胞对某些类型DNA损伤的反应,并与免疫多样性的产生有关。这些功能中的每一个都依赖于MutSα(MSH2*MSH6异二聚体)。这种蛋白质复合物的失活在大约一半已知的遗传性非息肉病性结直肠癌家族中导致肿瘤发生,并且也发生在各种组织的散发性肿瘤中。在这里,我们描述了与不同DNA底物结合的人MutSα的一系列晶体结构,每种底物已知会引发MMR途径的多种生物学反应之一。所有损伤都以类似的方式被识别,这表明在该损伤识别步骤下游的事件中产生了MutSα对DNA损伤的依赖性反应的多样性。这项研究还允许对致癌突变进行精确映射,并且进一步提出了异二聚体内不同区域之间变构通讯的结构途径。

相似文献

1
Structure of the human MutSalpha DNA lesion recognition complex.人类MutSα DNA损伤识别复合物的结构。
Mol Cell. 2007 May 25;26(4):579-92. doi: 10.1016/j.molcel.2007.04.018.
2
Loss of DNA mismatch repair genes leads to acquisition of antibiotic resistance independent of secondary mutations.DNA错配修复基因的缺失导致抗生素耐药性的获得,且与二次突变无关。
bioRxiv. 2025 Jun 25:2025.06.20.660601. doi: 10.1101/2025.06.20.660601.
3
Short-Term Memory Impairment短期记忆障碍
4
Lynch Syndrome林奇综合征
5
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
10
Escherichia coli MutS tetramerization domain structure reveals that stable dimers but not tetramers are essential for DNA mismatch repair in vivo.大肠杆菌MutS四聚化结构域的结构表明,稳定的二聚体而非四聚体对于体内DNA错配修复至关重要。
J Biol Chem. 2007 Jun 1;282(22):16345-54. doi: 10.1074/jbc.M700858200. Epub 2007 Apr 10.

引用本文的文献

1
Molecular analysis of three DNA mismatch repair protein variants in Chinese families with suspected Lynch syndrome.对疑似林奇综合征的中国家系中三种DNA错配修复蛋白变体的分子分析。
Front Med (Lausanne). 2025 Jul 29;12:1635964. doi: 10.3389/fmed.2025.1635964. eCollection 2025.
2
CRISPR-based therapeutic genome editing for inherited blood disorders.基于CRISPR的遗传性血液疾病治疗性基因组编辑
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01236-y.
3
Therapeutic targeting of mismatch repair-deficient cancers.错配修复缺陷型癌症的治疗靶向作用
Nat Rev Clin Oncol. 2025 Jul 10. doi: 10.1038/s41571-025-01054-6.
4
Elucidation of multiple high-resolution states of human MutSβ by cryo-EM reveals interplay between ATP/ADP binding and heteroduplex DNA recognition.通过冷冻电镜解析人类MutSβ的多个高分辨率状态揭示了ATP/ADP结合与异源双链DNA识别之间的相互作用。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf604.
5
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer.用于预防与MSH6种系致病变异相关的结直肠癌的单基因疾病植入前基因检测。
BMC Cancer. 2025 Jul 1;25(1):1131. doi: 10.1186/s12885-025-14226-5.
6
Prime Editing in Dividing and Quiescent Cells.分裂细胞和静止细胞中的碱基编辑
Int J Mol Sci. 2025 Apr 11;26(8):3596. doi: 10.3390/ijms26083596.
7
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers.微卫星高度不稳定/错配修复缺陷型癌症的流行病学、发病机制、生物学特性及不断发展的治疗方法
Nat Rev Clin Oncol. 2025 Apr 3. doi: 10.1038/s41571-025-01015-z.
8
Analyzing pathogenic variants in mismatch repair genes: personalized prevention strategies for lynch syndrome in Chinese families.分析错配修复基因中的致病变异:中国家庭林奇综合征的个性化预防策略
Front Med (Lausanne). 2025 Mar 14;12:1527249. doi: 10.3389/fmed.2025.1527249. eCollection 2025.
9
Msh2-Msh3 DNA-binding is not sufficient to promote trinucleotide repeat expansions in Saccharomyces cerevisiae.Msh2-Msh3与DNA的结合不足以促进酿酒酵母中的三核苷酸重复序列扩增。
Genetics. 2025 Mar 17;229(3). doi: 10.1093/genetics/iyae222.
10
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma.免疫治疗反应性局部晚期直肠腺癌患者中一种生殖系错义MSH2变异导致的诊断挑战
Cancer Rep (Hoboken). 2024 Dec;7(12):e70037. doi: 10.1002/cnr2.70037.